IE850495L - Bromocriptine compositions - Google Patents

Bromocriptine compositions

Info

Publication number
IE850495L
IE850495L IE850495A IE49585A IE850495L IE 850495 L IE850495 L IE 850495L IE 850495 A IE850495 A IE 850495A IE 49585 A IE49585 A IE 49585A IE 850495 L IE850495 L IE 850495L
Authority
IE
Ireland
Prior art keywords
pharmaceutically acceptable
bromocriptine
compositions
bromocriptine compositions
bromocriptin
Prior art date
Application number
IE850495A
Other versions
IE58235B1 (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE850495L publication Critical patent/IE850495L/en
Publication of IE58235B1 publication Critical patent/IE58235B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pharmaceutical prepn. with controlled release after oral application container Bromocriptin, a pharmaceutically acceptable hydrophilic swellable substance and a pharmaceutically acceptable inert fatty material. [FR2560047A1]
IE49585A 1984-02-29 1985-02-28 Bromocriptine compositions IE58235B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions

Publications (2)

Publication Number Publication Date
IE850495L true IE850495L (en) 1985-08-29
IE58235B1 IE58235B1 (en) 1993-08-11

Family

ID=10557324

Family Applications (1)

Application Number Title Priority Date Filing Date
IE49585A IE58235B1 (en) 1984-02-29 1985-02-28 Bromocriptine compositions

Country Status (26)

Country Link
JP (1) JPS60202812A (en)
AT (1) AT387716B (en)
AU (2) AU586621B2 (en)
BE (1) BE901810A (en)
CA (1) CA1256374A (en)
CH (2) CH666406A5 (en)
DE (1) DE3505743C2 (en)
DK (1) DK175016B1 (en)
ES (1) ES8705223A1 (en)
FR (1) FR2560047B1 (en)
GB (1) GB8405227D0 (en)
GR (1) GR850506B (en)
HK (1) HK85490A (en)
HU (1) HU196121B (en)
IE (1) IE58235B1 (en)
IL (1) IL74459A (en)
IT (1) IT1199948B (en)
LU (1) LU85791A1 (en)
MX (1) MX9203626A (en)
NL (1) NL194231C (en)
NZ (1) NZ211247A (en)
PH (1) PH23266A (en)
PT (1) PT80015B (en)
SE (2) SE8500961L (en)
SG (1) SG69390G (en)
ZA (1) ZA851546B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules
DE3722383A1 (en) * 1986-07-14 1988-01-28 Sandoz Ag NEW USE OF BROMOCRIPTIN
DE4041563A1 (en) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh METHOD FOR PRODUCING ACTIVE MICROPARTICLES FROM HYDROLYTICALLY DEGRADABLE POLYMERS
US5569450A (en) * 1993-03-17 1996-10-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128902C (en) * 1960-06-06
CH507249A (en) * 1968-05-31 1971-05-15 Sandoz Ag Process for the preparation of 2-bromo-a-ergocryptine
DE2553026A1 (en) * 1974-12-04 1976-06-10 Schlueter Edelfett Compressible tablet formulations - contg branched fatty alcohols and/or fatty acid triglycerides and/or fatty alcohol esters as hydrophobic carrier materials
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
IT1158162B (en) * 1977-12-22 1987-02-18 Sandoz Ag PHARMACEUTICAL COMPOSITIONS BASED ON DERIVATIVES OF ERGOLENA AND ERGOLINA
DE3045135A1 (en) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach BODEGRADABLE POLYMERS CONTAINING PHARMACEUTICAL COMPOSITIONS
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3216870A1 (en) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen PHARMACEUTICAL PREPARATIONS WITH A CYTOSTATIC EFFECT
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Also Published As

Publication number Publication date
JPH0448776B2 (en) 1992-08-07
NZ211247A (en) 1989-02-24
PH23266A (en) 1989-06-23
AU586621B2 (en) 1989-07-20
HUT38254A (en) 1986-05-28
IT8547703A0 (en) 1985-02-20
CH667009A5 (en) 1988-09-15
CA1256374A (en) 1989-06-27
DK86785D0 (en) 1985-02-26
ES8705223A1 (en) 1987-05-01
JPS60202812A (en) 1985-10-14
AU3913685A (en) 1985-09-05
NL8500417A (en) 1985-09-16
ZA851546B (en) 1986-10-29
HK85490A (en) 1990-10-25
DE3505743C2 (en) 1995-02-16
AU3500689A (en) 1989-09-14
CH666406A5 (en) 1988-07-29
PT80015B (en) 1987-09-18
AT387716B (en) 1989-03-10
NL194231B (en) 2001-06-01
BE901810A (en) 1985-08-26
IT8547703A1 (en) 1986-08-20
MX9203626A (en) 1992-09-01
GR850506B (en) 1985-06-28
ES540807A0 (en) 1987-05-01
DK86785A (en) 1985-08-30
ATA58085A (en) 1988-08-15
FR2560047A1 (en) 1985-08-30
AU618599B2 (en) 1992-01-02
SG69390G (en) 1990-10-26
GB8405227D0 (en) 1984-04-04
IL74459A (en) 1988-12-30
SE8500961L (en) 1985-08-30
NL194231C (en) 2001-10-02
IL74459A0 (en) 1985-05-31
FR2560047B1 (en) 1988-01-15
DE3505743A1 (en) 1985-08-29
DK175016B1 (en) 2004-04-26
HU196121B (en) 1988-10-28
LU85791A1 (en) 1985-12-11
SE8500961D0 (en) 1985-02-27
SE462259B (en) 1990-05-28
IE58235B1 (en) 1993-08-11
IT1199948B (en) 1989-01-05
PT80015A (en) 1986-02-10

Similar Documents

Publication Publication Date Title
IE880281L (en) Swellable pellets
AU558331B2 (en) Solid medicament formulations containing nifedipine, and processes for their preparation
AU580076B2 (en) Dental preparation, article and method for storage and delivery thereof
AU3326289A (en) Matrix for release of active ingredients
AU2732288A (en) Polyethylene wax, and a process for the preparation thereof
CY1764A (en) New drug preparation with controlled release of the active compound, and a method for the manufacture thereof
AU578703B2 (en) Dialkoxypyridines, process for their preparation, their use and medicaments containing them
AU8124387A (en) Composition for feeding ruminants containing a biologically active substance and its preparation
AU2707788A (en) Sustained release pharmaceutical composition
AU7792987A (en) Administration and dosage form for drug active agents, reagents or the like and process for the preparation thereof
AU4595689A (en) Medicinal aerosol formulations
AU4464897A (en) Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix
EP0137632A3 (en) Physiologically active substance k-252, process for producing same and a pharmaceutical composition containing same
ZA874899B (en) Controlled release dosage form comprising acetaminophen,pseudeophedrine and dexbrompheniramine
MY101029A (en) Bromocriptine compositions
AU8096591A (en) Composition for solid pharmaceutical preparations containing active vitamins d3 and process for preparation thereof
AU2837089A (en) New indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
AU2653788A (en) Manumycin derivatives, a process for the preparation thereof, and the use thereof
AU1446688A (en) New 2-acylpyrrolidine derivatives, a process for the preparation thereof, agents containing them, and their use
AU4246489A (en) New benzoxazolinone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
AU1888488A (en) Substituted benzimidazoles, a process for the preparation thereof, pharmaceutical formulations containing them, and theuse thereof
HK85490A (en) Bromocriptine compositions
BG101080A (en) Medicamentous form of carbamasepin with delayed release of the active substance
AU3499389A (en) Compounds with central analgesic activity, process for their preparation and pharmaceutical compositions containing them
IE822062L (en) Human proinsulin formulations

Legal Events

Date Code Title Description
MK9A Patent expired